These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 9123684)

  • 21. Aromatic and heterocyclic amine metabolism and phenotyping in humans.
    Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1991; 372():33-47. PubMed ID: 1956928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [N-acetylation polymorphism versus differentiation of organic susceptibility to carcinogenic effect of homo- and heterocyclic aromatic amines].
    Lutz W; Barański B; Krajewska B
    Med Pr; 1994; 45(4):343-9. PubMed ID: 7968503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance.
    Azémar MD; Comperat E; Richard F; Cussenot O; Rouprêt M
    Urol Oncol; 2011; 29(2):130-6. PubMed ID: 19762256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bladder tumor histo-seminar - case 5: Urothelial carcinoma with squamous differentiation (basal type)].
    Allory Y
    Ann Pathol; 2016 Dec; 36(6):390-393. PubMed ID: 27838080
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates.
    Solomon JP; Hansel DE
    Adv Anat Pathol; 2015 Mar; 22(2):102-12. PubMed ID: 25664945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical relevance of acetylator phenotyping in 196 urothelial tumor patients].
    Schöps W; Prior V; Golka K; Blaszkewicz M; Cascorbi I; Roots I; Bolt HM; Kierfeld G
    Urologe A; 1997 Jan; 36(1):64-7. PubMed ID: 9123684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of the human acetylator polymorphism in spontaneous disorders.
    Evans DA
    J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
    Hein DW
    Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acetylation phenotype as a biomarker of sensitivity to the carcinogenic effect of aromatic amines].
    Indulski JA; Krajewska B; Lutz W
    Med Pr; 1992; 43(5):427-35. PubMed ID: 1293477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.